In this issue:
Clinical features and mortality from the first 220 cases of VITT in the UK
Bleeding and thrombosis may be adverse events after CAR T-cell therapy
Validation of PROMIS Profile-29 in adults with haemophilia in the Netherlands
Lower recurrent VTE but higher bleeding in incidental versus symptomatic cancer-related VTE
Rivaroxaban thromboprophylaxis in elderly acutely ill medical patients
Does prehospital antiplatelet therapy protect against death from COVID-19?
Simoctocog alfa demonstrates low immunogenicity in severe haemophilia A
Intravitreal treatment for retinal vein occlusion confers long-term visual acuity benefits
Gene therapy is cost-effective for severe haemophilia B
Addition of ATRA to LD-RTX improves overall and sustained response in ITP
Please login below to download this issue (PDF)